GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Deferred Tax

BIO-FD&C Co (XKRX:251120) Deferred Tax : ₩1,616 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BIO-FD&C Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

BIO-FD&C Co's change in deferred tax for the three months ended in Mar. 2024 was ₩240 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,616 Mil.

BIO-FD&C Co Deferred Tax Historical Data

The historical data trend for BIO-FD&C Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-FD&C Co Deferred Tax Chart

BIO-FD&C Co Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22
Deferred Tax
Get a 7-Day Free Trial -125.11 431.03 - - 1,108.10

BIO-FD&C Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 191.54 298.94 484.13 592.17 240.45

BIO-FD&C Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,616 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BIO-FD&C Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of BIO-FD&C Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

BIO-FD&C Co (XKRX:251120) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Deferred Tax
Comparable Companies
XKRX:389030 XKRX:067370 XKRX:353810 XKRX:234690 XKRX:203400 XKRX:140610 XKRX:166480 XKRX:284620 XKRX:308080 XKRX:365270 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
30, Songdomirae-ro, Yeonsu-gu, 509-512, B07, A-dong, Smartvalley, Incheon, KOR
Website
http://www.biofdnc.com
BIO-FD&C Co Ltd is engaged in dealing with anti-aging and health materials using sustainable bio-cultivation technology. Its products include Plant cell, Peptide, Herbal Extract and Biomolecule.

BIO-FD&C Co (XKRX:251120) Headlines

No Headlines